Endo’s Par Delivers On Nevakar Alliance With First Launch

Launch Of Pre-Mixed Ephedrine Sulfate Follows 2018 Deal With 505(b)(2) Specialist

Endo’s Par has announced the first launch under a longstanding US collaboration with 505(b)(2) specialist Nevakar, in the form of pre-mixed ephedrine sulfate injection in a ready-to-use 50mg/10ml single-use vial.

black chalk board with lettering ephedrine
Pre-mixed ephedrine sulfate is the first launch through Endo’s alliance with Nevakar • Source: LightField Studios Inc. / Alamy Stock Photo

Endo has delivered on its alliance with US 505(b)(2) injectables specialist Nevakar by launching pre-mixed ephedrine sulfate injection in a ready-to-use 50mg/10ml single-use vial.

Having first struck a deal with Nevakar in 2018 – when Endo announced that the partners would develop and market...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin